Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Aggression × Ifosfamide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 7 Lymphoma, Large B-Cell, Diffuse 6 Osteosarcoma 4 Lymphoma 4 Wilms Tumor 3 Neuroectodermal Tumors, Primitive, Peripheral 3 Neoplasms 3 Carcinoma, Renal Cell 3 Retinoblastoma 2 Optic Nerve Glioma 2 Neuroblastoma 2 Melanoma 2 Medulloblastoma 2 Lymphoma, Non-Hodgkin 2 Hodgkin Disease 2 Carcinoma, Hepatocellular 2 Astrocytoma 2 Waldenstrom Macroglobulinemia 1 Uveal Melanoma 1 Unspecified Adult Solid Tumor, Protocol Specific 1 Thrombocytopenia 1 Testicular Neoplasms 1 Stomach Neoplasms 1 Solid Tumors 1 Sarcoma, Synovial 1 Sarcoma, Ewing 1 Sarcoma, Alveolar Soft Part 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Rectal Neoplasms 1

Interventions

selinexor 1 Rituximab 1 Ifosfamide 1 Etoposide 1 Dexamethasone 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02471911 2022-04-12

KPT-330+RICE

Weill Medical College of Cornell University

Phase 1 Completed

Aggression, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon ⚡